Dextech Medical AB reported earnings results for the third quarter and nine months ended March 31, 2022. For the third quarter, the company reported sales was SEK 0.151 million compared to SEK 0.234 million a year ago. Net loss was SEK 1.14 million compared to SEK 1.5 million a year ago. Basic loss per share from continuing operations was SEK 0.06 compared to SEK 0.1 a year ago.
For the nine months, sales was SEK 0.228 million compared to SEK 0.471 million a year ago. Net loss was SEK 3.22 million compared to SEK 4.59 million a year ago. Basic loss per share from continuing operations was SEK 0.2 compared to SEK 0.31 a year ago.